ENDRA Life Sciences Inc. 8K

ASP Isotopes’ subsidiary Noble Africa will merge with a subsidiary of ENDRA Life Sciences, raise about $50 million in a concurrent private placement, and form a Nasdaq‑listed helium company named Noble Africa Inc., majority owned by ASP Isotopes.

On June 25, 2026, ASP Isotopes Inc. and ENDRA Life Sciences Inc. announced that ASP Isotopes’ wholly owned subsidiary Noble Africa LLC, which holds its interest in Renergen Limited and the Virginia Gas (helium) Project, will merge with a subsidiary of ENDRA, with Noble Africa as the surviving entity, and that the combined company will be renamed Noble Africa Inc. and seek listing on Nasdaq under the ticker NOBA. In conjunction with the merger, Noble Africa has secured commitments for a concurrent private placement expected to raise approximately $50 million in gross proceeds (about $20 million from ASP Isotopes as lead investor and roughly $30 million from other investors, including $750,000 from ASP Isotopes’ directors and management), which is expected to close immediately prior to the merger. Post-closing, ASP Isotopes is expected to own about 89% of the combined company, pre-merger ENDRA stockholders about 3%, and other private placement investors about 7%. The transactions have been approved by the boards of both ASP Isotopes and ENDRA, are targeted to close in the third or fourth quarter of 2026 subject to SEC registration effectiveness, ENDRA stockholder approval, Nasdaq listing, and other customary conditions, and the combined company will initially be led by Paul E. Mann and Nick Mitchell with a five‑member board primarily designated by ASP Isotopes and one director designated by ENDRA.

Filing Facts

CIK

1681682

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-071804

Alert Tier

8